Article
Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome.
Pediatric cardiology - 1 Jan 2000
Chatrath R, Bell C M, Ackerman M J
Abstract excerpt
Beta-blocker therapy is one of the principal therapies for congenital long-QT syndrome (LQTS). However, breakthrough cardiac events occur while being treated with beta-blockers. We sought to determine the frequency of and clinical correlates underlying beta-blocker therapy failures in genotyped, symptomatic LQTS probands. The medical records were analyzed only for genotyped LQTS probands who presented with a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
